Officials at BioMarin Inc. believe themselves to be fortunate in determining fairly early that their lead product, Neutralase, probably won't make it to market. (BioWorld Today)

Officials at BioMarin Inc. believe themselves to be fortunate in determining fairly early that their lead product, Neutralase, probably won't make it to market. (BioWorld Today)

Genta Inc. received its first drug approval Thursday when the FDA cleared Ganite for the treatment of cancer-related hypercalcemia that is resistant to hydration. (BioWorld Today)

Genta Inc. received its first drug approval Thursday when the FDA cleared Ganite for the treatment of cancer-related hypercalcemia that is resistant to hydration. (BioWorld Today)